Skip to main content
Update Location

My Location

Update your location to show providers, locations, and services closest to you.

Enter a zip code
Or
Select a campus/region
(352) 733-0111

Clinical trials

  • REPLENISH

    The purpose of this study is to demonstrate the efficacy and safety of secukinumab 300 milligram (mg) and 150 mg administered subcutaneously (s.c.) for 52 weeks in combination with prednisone tapered over 24 weeks in adult participants with PMR who…

    Investigator
    Roland Staud
    Ages
    50 Years - N/A
    Sexes
    All
  • APL2-C3G-310

    This is a Phase 3 study to assess the efficacy and safety of twice-weekly subcutaneous (SC) doses of pegcetacoplan compared to placebo in patients with C3 glomerulopathy (C3G) or immune-complex membranoproliferative glomerulonephritis (IC-MPGN) on…

    Investigator
    Lawrence R Shoemaker
    Ages
    12 Years - N/A
    Sexes
    All